Humanigen

Lenzilumab Explainer

At the height of the novel coronavirus outbreak, we created an animated film that distilled information about the Phase III Study of Lenzilumab in COVID-19 patients for the clinical-stage biopharmaceutical company Humanigen and educated and informed the public about cytokine storm, a common complication of the virus.

Approach

In a rapid 3-week turnaround environment, our team of agile creators and designers used colorful shape-based animations and incorporated the latest information to distill the complexity of this cutting edge therapy.

Impact

This film was released shortly after the announcement that Humanigen would commence the Phase III Study of Lenzilumab in COVID-19 patients and is available for the public on their website, social media, and press releases.

When Humanigen rang the opening bell for Nasdaq in 2020, scenes from the film were projected in Times Square!

8

language translations

1000+

animated Lenz balls

Let’s work together.

Our team is ready to start the conversation.

Join our team.

Interested in working at RF Studio53? We would love to meet you.

Send your resume to Aiden@RuderFinn.com